ABSTRACT: Spatial and temporal expression and regulation of the antioxidant enzymes, glutathione peroxidase (GSH-Px), glutathione disulfide reductase (GSSG-Rd) may be important in determining cellspecific susceptibility to embryotoxicants. Creation of tissue-specific ontogenies for antioxidant enzyme activities during development is an important first step in understanding regulatory relationships. Early organogenesis-stage embryos were grouped according to the somite number (GD 9-13), and fetuses were evaluated by gestational day (GD 14-21). GSH-Px activities in the visceral yolk sac (VYS) increased on consecutive days from GD 9 to GD 13, representing a 5.7-fold increase during this period of development. GSH-Px activities in VYS decreased after GD 13, ultimately constituting a 37% decrease at GD 21. Head, heart, and trunk specific activities generally increased from GD 9 to GD 13 albeit not to the same magnitude as detected in the VYS. GSSG-Rd activities showed substantial increases in the VYS from GD 9 to GD 13, 6.3-fold and decreased thereafter to 50% by GD 21. The greatest changes in enzyme activities were noted in the period between GD 10 and GD 11, where the embryo establishes an active cardiovascular system and begins to convert to aerobic metabolism. Generally, from GD 14-21, embryonic organ GSH-Px and GSSG-Rd activities either remained constant or increased as gestation progressed. These studies suggest the importance of the VYS in dealing with ROS and protecting the embryo. Furthermore, understanding the consequences of lower antioxidant activities during organogenesis may help to pinpoint periods of teratogenic susceptibility to xenobiotics and increased oxygen. C
INTRODUCTION
Early experimental evidence indicates that embryos are most susceptible to toxic insult during the period of organogenesis [1] . The mammalian embryo is metabolically active, and as gestation proceeds, the utilization of oxygen increases when aerobic metabolic processes mature to support cellular function [2] . During organogenesis, oxygen requirements for optimal embryonic growth in vitro are shown to be stage specific, increasing from 5% O 2 on gestational day (GD) 9 to 95% on GD 11. Within this interval the pathways of energy metabolism shifts from predominantly anaerobic glycolysis to aerobic glycolysis, active Krebs cycle function, and oxidative phosphorylation [3] [4] [5] [6] . Since these latter processes require O 2 , embryonic growth is dependent on significantly increasing O 2 concentrations [2, [7] [8] [9] [10] . As embryonic requirements for O 2 increases, the probability of reactive oxygen species (ROS) formation also increases, and the cell must adapt, removing ROS and preventing cell damage and death.
Excessive generation of ROS can initiate changes that are detrimental for the cell, namely lipid peroxidation, DNA breakage, protein degradation, and enzyme deactivation [11] . However, a finite amount of ROS is generated during the normal physiological conditions that exist during organogenesis, and its regulation is important for maintaining viability and normal cell function. The generation of ROS is initiated by a single-election reduction of O 2 to yield intermediates, which transfer one electron to O 2 with the resulting formation of superoxide anion radical (O − 2 ). Superoxide anion radical undergoes dismutation to hydrogen peroxide (H 2 O 2 ) by superoxide dismutase (SOD). Hydrogen peroxide can then be detoxified to water but under conditions where protective measures are overwhelmed, H 2 O 2 will be converted to the highly reactive hydroxyl radical (HO•) via the transition metal dependent Harber-Weiss reaction [11] . If not removed, the hydroxyl radical can produce structural and functional damage that eventually leads to cell death.
Glutathione (GSH) is the most abundant endogenous intracellular thiol (0.2-10 mM), found in most mammalian and many prokaryotic cells. It is well known for its cellular protective roles against ROS and free radicals by acting as a radical scavenger and intracellular antioxidant [12, 13] . Glutathione is also known to be an important regulatory element because of its role in maintaining intracellular redox status which, in turn, has been shown to regulate cellular functions including enzyme activities, signal transduction, macromolecular synthesis, cell proliferation, and maintenance of membrane integrity [13, 14] . Since GSH serves in these capacities in the cell, the regulation of GSH status is of importance in protection against toxicity.
Enzyme pathways exist within the cell to combat the hazardous effects of ROS by acting directly as an antioxidant or regulating GSH status. Molecular oxygen can be converted into ROS via several routes such as, electron leakage in the mitochondria, cellular oxidases (lipoxygenase, cyclooxygenase, xanthine oxidase, etc.), and xenobiotics [11] . The anticonvulsant mephenytoin, the alkylating cancer agent cyclophosphamide, and the keratolytic agent isotretinoin are all known teratogens which are capable of producing oxidative stress as a result of increased production of free radical intermediates and/or subsequent ROS formation. Compounds like paraquat, doxorubicin, and nitrobenzene, which are also teratogens, are detrimental due to their ability to redox cycle [15] [16] [17] [18] [19] [20] . Although the superoxide anion can spontaneously form hydrogen peroxide at physiological pH, this reaction is rather slow. Superoxide dismutase catalyzed detoxication of superoxide anion to hydrogen peroxide is much more efficient in removing ROS from the cell and is relatively independent of pH. If not removed, hydrogen peroxide can readily cross plasma membranes and can be effectively metabolized by catalase or glutathione peroxidase (GSH-Px) with GSH acting as a cofactor, resulting in glutathione disulphide (GSSG) and water [11] .
Moreover, GSH can interact with ROS independent of GSH-Px, becoming oxidized to GSSG and reducing ROS in the process [11] .
Whether formed spontaneously or from reactions involving GSH-Px, GSSG can be recycled back to GSH enzymatically via GSSG-Rd using NADPH as the critical cofactor [11, 12, 21] .
Control of the GSH/GSSG cycle prevents drastic changes in both GSH and GSSG concentrations and allows for shorter periods of redox imbalance. Recent advances in our understanding of molecular regulation of gene expression and signal transduction suggest an important role of GSH and redox status. The developmental associations of antioxidant activities and redox status are, therefore, closely linked to cell and tissue differentiation [1, [22] [23] [24] . During differentiation, cells become increasingly oxidized and changes in antioxidant function include a drop in intracellular GSH content and an increase in GSSG as GSH reacts with ROS [25, 26] . Given the major role of GSH in maintaining cellular redox balance and the significance of this balance during differentiation, proliferation, and apoptosis, additional oxidative stress caused by chemical exposure could pose a serious threat to the regulation of normal growth and development, and further diminish the capacity of tissues to biotransform xenobiotics [11] .
Glutathione peroxidase (GSH-Px) and glutathione disulfide reductase (GSSG-Rd) are directly involved in the regulation of GSH and intracellular redox status. Inherent spatial and temporal variations in GSH-Px and GSSG-Rd specific activities may predispose certain cells or tissues to oxidative damage, redox imbalance, and misregulation of particular intracellular events important during embryonic maturation. Changes in redox status not only predispose the embryo to oxidative stress but are also known to modulate changes in gene expression [26,27 and reviewed in 28,29] . Such differences may be useful in understanding cell and species selectivity of various teratogens.
MATERIALS AND METHODS

Chemicals
Sodium azide, ␤-NADPH, glutathione, glutathione disulfide, glutathione reductase (Type III: from Bakers Yeast), hydrogen peroxide (H 2 O 2 ), superoxide dismutase (from Bovine), and epinephrine were all obtained from the Sigma Chemical Company (St. Louis, Mo.). All other chemicals and reagents were of purest grade commercially available.
Animals and Tissue Preparation
Primagravida Sprague-Dawley rats were timemated and used in all experiments. Day 0 of gestation was designated the morning following copulation as indicated by a sperm-positive vaginal smear. Animals were obtained on gestation days 6-9 from the Reproductive Science Program, Small Animal Core, University of Michigan, and maintained on a 12-h light/ 12-h dark cycle until explantation on the designated gestational day. Rats were allowed unrestricted access to food and water.
Developmental stages were categorized by ranges of somite numbers. Range one is somite number 0-12 which represent gestational days GD 9 through GD 10. Range two includes somite numbers 13-20 (GD 10), and range three encompasses somite numbers 21-28 (GD 11). Range four includes embryos of 29 or more somites, corresponding to GD 12. At each specific time point, conceptuses were carefully removed, placed, and washed in warmed Hank's Balanced Salt Solution (HBSS; pH 7.4). One or two embryos and visceral yolk sacs (VYSs) were stored in microcentrifuge tube containing an appropriate buffer. Heads, hearts, and trunks were also dissected from the embryo and placed in a separate tube. Samples were frozen and stored at −70
• C until processed for enzyme assay. For tissues removed at later stages of development, fetuses were dissected free of the uterus and immediately decapitated on ice. One to two litters were sacrificed at each time point of the study. The brain, heart, liver, lung, and kidney were excised and washed with cold HBSS, and then stored in test tubes with appropriate buffers for enzyme assay. Placentae and VYSs were carefully removed prior to collection of other samples, snap-frozen, and stored at −70
• C until analysis.
Superoxide Dismutase Assay
Conceptuses collected in somite ranges one through four were separated into embryos and VYS and were placed in groups (as described earlier) of 2 in 200 mL of 50 mM Tris-HCl (pH 7.4). The frozen samples were thawed and sonicated before assay. The SOD assay was performed as originally described by Sun and Zigman [30] . The reaction mixture of 200 mM sodium carbonate/EDTA and 0.3 mM epinephrine (in 0.1 N HCl) were made fresh prior to each assay. One hundred and fifty microliters of sodium carbonate/EDTA and 20 L sample or buffer (for blank) were added to each cuvette and allowed to warm to 30
• C for 5 min. To activate the reaction, 30 L epinephrine was added to the final mixture in the dark. SOD activity was determined spectrophotometrically with a Beckman BU-650 spectrophotometer by measuring the formation of adrenochrome at 320 nm at 30
• C for 10 min. SOD activity was determined by the percent inhibition of the control [30] . One unit of activity was defined as the amount of enzyme producing a 50% inhibition of the conversion of epinephrine to adrenochrome, measured by change in absorbency. Therefore, higher numbers correlate with less SOD activity as more homogenate is needed to produce a 50% inhibition. Specific activities were determined as units of activity per milligram protein. Protein was measured using the Bradford assay [31] .
Glutathione Peroxidase Assay
The GSH-Px assay was performed as originally described by Lawrence and Burk [32] . Samples were put in 50 mM potassium phosphate (K 2 HPO 4 ; pH 7.0) buffer and were frozen in liquid nitrogen and stored at −70
• C. At the time of assay, samples were thawed at room temperature, homogenized by ultrasonic tissue disruption and placed on ice. A Beckman BU-650 spectrophotometer was used for this spectrophotometric assay. Each cuvette contained 150 L of reaction mixture with 50 mM potassium phosphate (K 2 HPO 4 ; pH 7.0) solution, 1 mM EDTA, 1 mM NaN 3 , 2 mM NADPH, and 1 mM GSH. Six microliters of GSSG-Rd (1 E.U./ml) was added at the last step of reaction mixture. Blank cuvettes then received 50 L of K 2 HPO 4 buffer while sample cuvettes received 50 L of sample. All reactions were gently mixed and incubated at 30
• C for 4 min. To activate the reaction, 0.25 mM H 2 O 2 solution was added and mixed into each cuvette. Absorbency was immediately determined at a fixed wavelength of 340 nm for 4 min. The rate of NADPH oxidation correlates with the oxidation of H 2 O 2 by GSH-Px. Specific activities were calculated by dividing the rate of oxidation of NADPH (mol/min) by the milligrams of protein (nmol NADPH oxidized/min/mg protein). Protein was determined by the method of Bradford [31] . Concentrations of NADPH oxidized are calculated from the molar extinction coefficient (6.22
. A dilution of the sample was performed in order to obtain a linear enzymatic reaction. Each reaction was carried out in duplicate.
Glutathione Reductase Assay
The GSSG-Rd activity was measured using the method originally described by Carlberg and Mannervik [33] . Samples were placed in 0.2 M K 2 H PO 4 /2 mM EDTA (pH 7.0) buffer and frozen at −70
• C until analysis. At the time of assay, samples were thawed, homogenized by ultrasonic tissue disruption at room temperature, and immediately placed on ice. The reaction mixture consisted of 100 L of 0.2 M K 2 HPO 4 /EDTA (pH 7.0) solution, 10 L of 2 mM NADPH/Tris-HCl solution. All mixtures and solutions were prepared at room temperature. Blank cuvettes then received 80 L of deionized water while sample cuvettes received 30 L of deionized water and 50 L of sample. The reaction was initiated by adding and mixing 20 mM GSSG to all the tubes with the final volume of 200 L. NADPH oxidation was followed for 4 min and was recorded using a Beckman BU-650 spectrophotometer. The reduction of GSSG to GSH was determined indirectly by the measurement of the consumption of NADPH, as demonstrated by a decrease in absorbance at 340 nm as a function of time. Specific activities were calculated by dividing the rate of oxidation of NADPH (mol/min) by the milligrams of protein (nmol NADPH oxidized/min/mg protein). Protein content was determined by the method of Bradford [31] .
Statistical Analysis
Fetuses were collected from 8-12 pregnant dams for each time point (GD 9-21). A total of 15-20 embryos/fetuses/tissues (n) isolated from different litters were used for each individual assay. As no more than 2 embryos/fetuses/tissues from any one litter were used for a single assay, each embryo/fetus/tissue represents each individual litter while lessening the number of animals needed for this study. In addition, each embryo/fetus/tissue was assayed in duplicate to a reliable level of reproducibility. For differences between tissues, a one way ANOVA followed by a Tukey's Studentized Range (HSD) was used, where p values <0.05 were considered a demonstration of a significant difference.
RESULTS
Enzyme Activities: Early Organogenesis (GD 9-13)
Glutathione Peroxidase
Embryonic GSH-Px activity did not change significantly during the period of development from GD 9 to GD 13 ( Figure 1) . VYS GSH-Px activity remained constant from GD 9 (25.8 ± 2.75 nmol NADPH oxidized/min/mg protein) to GD 10 (17.4 ± 1.23 nmol NADPH oxidized/min/mg protein), but then increased significantly on GD 11 by 240% (59.2 ± 3.19 nmol NADPH oxidized/min/mg protein) from GD 10. This trend continued where GSH-Px activity increased by 35% from GD 11 to GD 12 (79.7 ± 3.61 nmol NADPH oxidized/min/mg protein) and by 21% from GD 12 to GD 13 (96.2 ± 0.76 nmol NADPH oxidized/min/mg protein).
Regional measurements of GSH-Px activity during early development showed relatively low GSH-Px activities in the head, heart, and trunk, ranging from 3.1 ± 0.67 nmol NADPH oxidized/min/mg protein (head) to 5.8 ± 0.1.02 nmol NADPH oxidized/min/mg protein (heart; Figure 2 ). No significant changes in GSH-Px activity was seen on GD 10, but significant increases in GSH-Px activity were detected on GD 11 in all tissues, increasing 8-fold in the head, 4.6-fold in the trunk, and 2.2-fold in the heart. While GSH-Px activities in the head (28.3 ± 1.46 nmol NADPH oxidized/min/mg protein) and trunk (33.7 ± 3.24 nmol NADPH oxidized/min/mg protein) remained relatively constant on GD 12, the heart GSH-Px activity increased to 38.2 ± 5.17 nmol NADPH oxidized/min/mg protein, an increase of 172% from that on GD 11. GD 13 GSH-Px activities in the head and trunk did not change significantly, but the heart GSH-Px increased by 19% to 45.4 ± 1.01 nmol NADPH oxidized/min/mg protein. 
Glutathione Disulfide Reductase
The GD 9 embryo contained very little GSSG-Rd activity (12.3 ± 0.74 nmol NADPH oxidized/min/mg protein) as compared to the GD 9 VYS (36.4 ± 4.06 nmol NADPH oxidized/min/mg protein, Figure 3) . Embryonic GSSG-Rd activity on GD 10 did not change significantly (10.1 ± 0.69 nmol NADPH oxidized/min/mg protein) but GSSG-Rd activity increased in the VYS by 40% to 51.0 ± 2.21 nmol NADPH oxidized/min/mg protein. Embryonic GSSG-Rd activity increased significantly on the following day (GD 11) by 158% to 26.5 ± 1.72 nmol NADPH oxidized/min/mg protein, but did not increase further on the following 2 days of development (GD 12: 26.0 ± 1.87 and GD 13: 29.2 ± 0.65 nmol NADPH oxidized/min/mg protein). While VYS GSSG-Rd activity increased to 63.0 ± 3.50 nmol NADPH oxidized/min/mg protein, an increase of 24% from GD 11, the greatest increase was detected on GD 12 where VYS GSSG-Rd activity increased by 126% to 124.4 ± 8.02 nmol NADPH oxidized/min/mg protein. VYS GSSG-Rd increased even further on GD 13 to 180.3 ± 6.26 nmol NADPH oxidized/min/mg protein, an increase of 27%.
On GD 9, head (3.8 ± 0.45 nmol NADPH oxidized/min/mg protein) and heart (4.2 ± 0.46 nmol NADPH oxidized/min/mg protein) GSSG-Rd activities were not statistically different, but the GSSGRd activity of the trunk (7.5 ± 0.63 nmol NADPH oxidized/min/mg protein) showed was significantly more, 97 and 78% of the head and heart, respectively (Figure 4) . GSSG-Rd activities in the head (4.4 ± 0.52 nmol NADPH oxidized/min/mg protein) and trunk (8.0 ± 0.49 nmol NADPH oxidized/min/mg protein) remained constant on GD 10 but increased signif- icantly in heart to 7.9 ± 1.03 nmol NADPH oxidized/ min/mg protein, an increase of 88%. The greatest increases in GSSG-Rd activity was detected on GD 11. The head showed the greatest increase (6.5-fold) to 28.4 ± 2.33 nmol NADPH oxidized/min/mg protein and was followed by that in the trunk (3.9-fold) to 31.5 ± 1.20 nmol NADPH oxidized/min/mg protein. The heart increased by 3.3-fold to 26.1 ± 2.94 nmol NADPH oxidized/min/mg protein. GSSG-Rd activities for the head and trunk did not significantly change on either GD 12 or GD 13. However, the heart increased on both GD 12 (34.0 ± 1.17 nmol NADPH oxidized/min/mg protein) by 30% and GD 13 (44.9 ± 2.11 nmol NADPH oxidized/min/mg protein) by 32%.
Superoxide Dismutase
Since this is an inhibition assay, lower SOD measurements reflect a greater SOD activity. Early organogenesis-staged (GD 9) embryos had relatively low levels of SOD, 9.6 ± 0.54 units SOD/mg protein ( Figure 5 ). As development progressed, embryonic SOD activity increased, 7.9 ± 0.20, 3.6 ± 0.14, and 3.3 ± 0.18 units SOD/mg protein for somite ranges 2 through 4 on GD 10, 11, and 12, respectively. The VYS during this same period (GD 9-12) also showed SOD activity changes. The least amount of SOD activity in the VYS was noted at GD 9, 11.2 ± 1.57 units SOD/mg protein ( Figure 5 ), but SOD increased every subsequent day, 9.2 ± 0.60 (GD 10), 4.6 ± 0.19 (GD 11), and 4.0 ± 0.17 (GD 12) units SOD/mg protein. No significant differences were detected between the embryo and VYS on GD 9, but statistically significant differences between the embryo and VYS were detected on each of the succeeding days, GD 10-GD 12. Closer inspection of SOD activities in regions of the embryo on GD 9 showed that the head, trunk, and heart all have relatively equal SOD activity (head: 5.4 ± 0.70; trunk: 5.5 ± 0.08; heart: 4.0 ± 1.57 units SOD/mg protein; Figure 6 ). However, statistically significant differences were detected on the following day (GD 10), where the trunk and heart showed 23% (5.5 ± 0.24 units SOD/mg protein) and 35% (4.6 ± 0.49 units SOD/mg protein) more SOD activity, respectively, than that in the head (7.1 ± 0.28 units SOD/mg protein). This trend reversed itself in the heart, and SOD activity decreased on GD 11 by 55% (7.1 ± 0.68 units SOD/mg protein), which was statistically different from the head (3.3 ± 0.41 units SOD/mg protein) and trunk (2.3 ± 0.14 units SOD/mg protein) SOD activities on GD 11, which both increased from the preceding day. Head and trunk continued to increase on GD 12 and measured 2.0 ± 0.05 and 1.7 ± 0.04 units SOD/mg protein and were statistically different from the SOD activity of the heart (6.8 ± 0.36 units SOD/mg protein).
Enzyme Activities: Late Organogenesis (GD 14-21)
Glutathione Peroxidase
Glutathione peroxidase activities of most embryonic tissues did not change during development from GD 14 to GD 21. Rat brain, lung, placenta, and heart GSH-Px activity fluctuated but basically remained constant where changes were not statistically significant (brain: increased 2%; lung: increased by 37%; placenta: increased by 28%; heart: decreased by 30%; Figure 7) . Tissues that did change significantly during this period were the liver (GD 14: 31.4 ± 1.71 nmol NADPH oxidized/min/mg protein) and the kidney (GD 16: 28.4 ± 2.25 nmol NADPH oxidized/min/mg protein), measuring increases in GSH-Px activity by 92% and 160% (from GD 14-16 to GD 21), respectively. Interestingly, the kidney did not show any significant changes until the day just prior to birth, nearly doubling from GD 20 (33.9 ± 1.76 nmol NADPH oxidized/min/mg protein) to GD 21 (73.8 ± 3.50 nmol NADPH oxidized/min/mg protein). The VYS was the single tissue that showed constitutively high levels of GSH-Px activity and was statistically different from most other tissues on GD 14 (68.2 ± 2.73 nmol NADPH oxidized/min/mg protein) but did not increase significantly during later phases of development, only increasing slightly by 12% (76.5 ± 3.57 nmol NADPH oxidized/min/mg protein).
Glutathione Disulfide Reductase
On GD 14, only one tissue showed considerably higher levels of GSH-Px activity as compared to other tissues and organs, the VYS (Figure 8 ). The GD 14 VYS showed 172.1 ± 9.91 nmol NADPH oxidized/min/mg protein, 207% higher than the next highest tissue, the liver (56.0 ± 1.94 nmol NADPH oxidized/min/mg protein). The brain, liver, kidney, and lung all increased during this period of development (GD 14-21), ranging from larger increases of 86% (liver: GD 14: 56.0 ± 1.94 nmol NADPH oxidized/min/mg protein; GD 21: 105.6 ± 6.70 nmol NADPH oxidized/min/mg protein) to smaller increases of 16% (kidney: GD 16: 55.7 ± 3.61 nmol NADPH oxidized/min/mg protein; GD 21: 64.7 ± 6.06 nmol NADPH oxidized/min/mg protein). No significant changes were detected in heart or the placenta during this time. The only tissue shown to considerably decrease over this period was the VYS, dropping from GD 14 (172.1 ± 9.91 nmol NADPH oxidized/min/mg protein) to GD 21 (93.8 ± 6.15 nmol NADPH oxidized/min/mg protein) by 45%. 
DISCUSSION
Intracellular redox gradients are believed to play an important role in cellular growth regulation and maturation of cellular function. Metabolically generated oxidants and cellular antioxidant status have been implicated as important factors that direct the initiation of developmental events such as differentiation and proliferation (22) (23) (24) (34) (35) (36) . Because several teratogens are capable of producing oxidative stress and subsequent changes in redox status, the delayed or precocious appearance of antioxidant enzymes such as SOD, GSH-Px, and GSSG-Rd in specific cell types may thus contribute to developmental regulation as well as the differential sensitivity to teratogens and developmental toxicants. The metabolic generation of ROS from dioxygen (HO•, O • − 2 and H 2 O 2 ) require the sequential action of SOD, GSH-Px, and GSSG-Rd for the efficient removal and protection from the potentially damaging oxygen intermediates. The primary aim of the studies described in this report is to evaluate developmental enzyme ontogenies and the relationships between GSH-dependent antioxidant enzymes, GSH-Px and GSSG-Rd. An overall assessment of how the capacity to maintain GSH status and overall redox homeostasis is altered by teratogens will require an understanding of the cellular environments in which these changes take place. Although not directly related to GSH status, a comparison of SOD activities was also included with the early embryonic stages because it was of interest to determine whether changes in GSH-Px activities were correlated with activities of the major enzyme responsible for the generation of its substrate, H 2 O 2 .
During the early developmental periods (GD 9-13), we demonstrated that embryonic GSH-Px and GSSGRd activities did not change significantly in the embryo proper, but increase several fold in the VYS. This suggests that the cells of the embryo may not be programmed to respond to the dramatic alterations in oxygen availability and metabolic activity that occurs (GD 10-11) as the heart and vascular systems become functional and the conceptus converts from predominantly anaerobic glycolysis to the citric acid cycle (CAC) and mature mitochondrial functions.
The rodent VYS completely surrounds the developing embryo at this stage of development and has been shown to have considerable metabolic activity as well as capacities for bioactivation and detoxication [15, 37] . We have reported that GSH oxidation and GSH-protein mixed disulfide production following xenobiotic insult are consistently greater in the VYS compared with the embryo proper so that the more dramatic increases for GSH-Px and GSSG-Rd over developmental time may reflect the special protective role of the VYS in terms of removal of ROS [38] . It is also of interest that the largest increment of increase for GSH-Px activity occurs during a 24-h interval corresponding to the transition from glycolysis to CAC activity and the onset of active circulation. We still do not understand the biochemical and molecular mechanisms that might combine to regulate increased expression of these enzymes, not the mechanisms that regulate their appearance and activities.
Superoxide dismutase activities continue to increase over the early developmental times (GD 9-12) and are not different between the embryo and VYS, nor do they appear to respond to the aforementioned shift in metabolic activity occurring between GD 10 and GD 11. In the embryo, SOD activities plateau and coincide with significant increases in GSH-Px after GD 12. Unlike GSH-Px and GSSG-Rd, SOD activities are not dependent on intermediary metabolism and the production of cofactors such as GSH and NADPH, making it possible for existing SOD activities to adequately convert ever increasing superoxide concentrations to H 2 O 2 without a regulated increase in expression. The temporal patterns of change and relative differences in activity between tissues we report are in agreement with previously published ontogenies [39] [40] [41] .
In order to understand whether the cell and tissue specific differences in antioxidant enzyme activities that exist in the embryo could help explain differential sensitivity to teratogens, we began by comparing different tissue segments within the embryo proper. Because removal and assay of specific organs was not practical or possible during the early phases of development, only heads, trunks, and hearts were compared. Relatively few differences in GSH-Px and GSSG-Rd activities were observed between the three tissue segments, again indicating the apparent indifference of the embryo proper in responding to metabolic and environmental changes. Significant increases of activity for both enzymes in the heart on GD 13 are the first signs of selective cell regulation in the embryo. Coincidentally, SOD activities show the opposite reaction in the heart, where activities decline with advancing gestation age. It could be argued that a functional placenta (GD 13) and maturation of SOD activity in other tissues are reducing the commitment of the heart for its own antioxidant protection.
As organs mature and sufficient quantities of tissue are available to facilitate accurate assays (GD 14-21), we were able to determine antioxidant enzyme activities in hearts, brains, liver, lung, kidney, VYS, and placenta during the fetal period. Our expectations were that, as organs mature and prepare for the transition to extra-uterine live they will begin to differentially express antioxidant enzymes, resulting in the increase of activities to levels necessary to protect cells from inherent metabolism-dependent ROS formation. In the process, these mature organs will assume a responsibility for the detoxication of ROS initially maintained by the VYS but which is lost with the shedding of the VYS. Nevertheless, until parturition occurs the rat VYS continues to maintain the highest GSH-Px and GSSGRd activities. The heart, lung, placenta, and brain show relatively minor changes in activity from GD 14 until term. A study of SOD and GSH-Px expression in mice confirms that these organs show relatively minor changes during the latter half of gestation but demonstrate the dramatic increases that can occur following parturition [39] . The most significant increases in activity occurring during the latter half of gestation appear in the kidney and liver for GSH-Px. A gradual increase in GSH-Px specific activity is observed in the liver during the latter half of the gestation period and is contrasted by a rapid rise of activity in the kidney just prior to parturition at GD 20. Mature kidney and liver both contain the metabolic capacity to produce large amounts of ROS but also develop the capacity to remove it. We are not surprised that activities increase just prior to term when the VYS and other maternal support systems are no longer available to afford protection to the neonate.
Based on the data provided in this report it is unwise to interpret the results in terms of developmental regulation and the related teratogenic responses with out consideration of the various dynamic changes relating to all of the regulatory pathways involved. The innate ability of cells to respond to oxidative stress and restore redox homeostasis is of considerable importance in terms of regulation and cellular protection. Following insult, responses may involve the increased availability of the cofactors GSH and NADPH or may include increased availability of the enzymes themselves. Amicarelli et al. [41] have shown recently that exposure of mouse conceptuses in whole embryo culture to the teratogen phenytoin results in significant alteration in antioxidant activities of GD 14 and GD 19. Phenytoin was shown to significantly increase GSSG-Rd and GSH-Px activities in the GD 14 fetal liver, but were conversely shown to significantly decrease the same activities on GD 19. These results suggest that care be taken not to assume that all responses of a given tissue remain the same over any developmental period. It is not known at this time whether teratogen-induced changes in the intracellular redox status is, in any way, directly related to the cellular modulation of antioxidant enzyme activity. This will remain an open question for further study.
The establishment of enzyme ontogeny profiles is only an approximation to the understanding of differences in organ function and their regulation development. They do, however, provide a more fundamental knowledge regarding the potential relationships between different organs and tissues in terms of their relative protective capacitates and reasons why embryonic cells have such different responses to chemical embryotoxicants and teratogens. Disturbances in the intracellular redox balance have been shown to play a major part in the control and regulation of normal developmental events such as proliferation and differentiation [22] [23] [24] 38, 42] . The capacity of cells and tissues to respond to chemical and environmental stresses and restore normal redox homeostasis may determine whether cells continue in a normal course of development or succumb to various stages of toxicity that could result in malformation, functional alterations, or death.
